1. The Carer QALY Trap and Altruism in Economic Evaluations

   • J. Mick Tilford
   • Aygul Tarlan

   Editorial 02 November 2023 Pages: 1553 - 1555

2. Modelling Spillover Effects on Informal Carers: The Carer QALY Trap

   • David J. Mott
   • Hannah Schirrmacher
   • Chris Skedgel

   Current Opinion Open access 02 September 2023 Pages: 1557 - 1561

3. Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies

   • Deborah A. Marshall
   • Brittany Gerber
   • Gillian R. Currie

   Scoping Review 18 August 2023 Pages: 1563 - 1588

   

4. Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations

   • Kumar Mukherjee
   • Necdet B. Gunsoy
   • Gian Luca Di Tanna

   Systematic Review Open access 25 July 2023 Pages: 1589 - 1601

   

5. Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens

   • David Teigen
   • Robert O. Opoka
   • Bjarne Robberstad

   Original Research Article Open access 18 July 2023 Pages: 1603 - 1615

   

6. Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework

   • Boshen Jiao

   Original Research Article 25 July 2023 Pages: 1617 - 1627

   

7. De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation

   • Peter Gal
   • Gyorgyi Feldmajer
   • Inger Smith

   Original Research Article Open access 28 July 2023 Pages: 1629 - 1639

   

8. Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland

   • Michaela Carla Barbier
   • Alicia Fengler
   • Oliver Gautschi

   Original Research Article Open access 12 August 2023 Pages: 1641 - 1655

   

9. Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom

   • Jason Gordon
   • Maria Gheorghe
   • Amer Al-Taie

   Original Research Article Open access 16 August 2023 Pages: 1657 - 1673